Coronary heart disease
Conditions
Interventions
Control group(Study1):According to the 2018 Chinese Guidelines for the Diagnosis and Treatment of Stable Coronary Heart Disease, education on secondary prevention of Coronary heart disease was provide
Home rehabilitation group(Study1):Based on the control group, patients in the home rehabilitation group participated in a hierarchical, phased training program. The main training method is the progres
Control group(Study2):According to the 2018 Chinese Guidelines for the Diagnosis and Treatment of Stable Coronary Heart Disease, education on secondary prevention of Coronary heart disease was provide
Remote home rehabilitation team(Study2):Based on the control group, patients in the home rehabilitation group participated in a hierarchical, phased training program. The main training method is the p
Sponsors
China-japan Friendship Hospital
Eligibility
Sex/Gender
All
Age
60 Years to 80 Years
Inclusion criteria
Inclusion criteria: Study1: 1. Coronary artery disease was confirmed by coronary angiography, and revascularization (PCI or CABG) was performed within 2-4 weeks. 2. 60 years old = age =80 years old; 3. Patients with cardiopulmonary dysfunction and NYHA grade I to II; 4.The subject or family members can use wearable devices; 5. Sign informed consent to participate in this study voluntarily. Study 2: 1. Coronary heart disease was diagnosed by coronary angiography, and PCI or CABG was performed; 2. 60 years old = age =80 years old; 3. There is cardiopulmonary dysfunction and heart function (NYHAI~II grade); 4. Participants or family members can use wearable devices; 5. Sign informed consent to participate in this study voluntarily.
Exclusion criteria
Exclusion criteria: Study1: 1. The patients with acute ST elevation myocardial infarction; 2. Left ventricular ejection fraction 180mmHg, diastolic blood pressure > 110mmHg); 5. combined with other serious diseases, such as severe liver and kidney dysfunction (ALT> 1.5 times the normal value, Scr> 1.5 times the normal value); Severe consumption state or malignant tumor; 6. Cognitive dysfunction or mental illness; 7. There are motor dysfunction; 8. Participating in other clinical investigators within one month; 9. The investigator judged that participation in this study was inappropriate. Study2: 1. Left ventricular ejection fraction 180mmHg, diastolic blood pressure >110mmHg); 4. Combined with other serious diseases, such as severe liver and kidney dysfunction (ALT>1.5 times the normal value, Scr > Normal value1.5 times); Severe consumption state or malignant tumor; 5. Cognitive dysfunction or mental illness; 6. People with motor dysfunction; 7. Participating in other clinical investigators within one month; 8. The investigators judged it inappropriate to participate in this study. ;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| VO2peak;SF-36; | — |
Secondary
| Measure | Time frame |
|---|---|
| 6MWD;SAQ;Health-related Quality of Life Scale;LVEF;Anxiety and depression scale;MoCA;Complex cardiovascular event;Borg Exercise perceived Fatigue Scale;IPAQ;Model promotion evaluation index; | — |
Countries
China
Contacts
Public ContactYang Peng
China-japan Friendship Hospital
Outcome results
None listed